A new endotoxin adsorption device in Gram-negative sepsis: use of immobilized albumin with the MATISSE adsorber.
MATISSE is a new endotoxin (ET) adsorption system. It comprises the FRESENIUS hemoadsorption machine 4008 ADS to maintain the extracorporeal circuits and disposables including the MATISSE-adsorber based on macroporous beads immobilized with human serum albumin. In vivo and in vitro experiments with this new compound had shown favourable ET elimination properties. In a first study 19 healthy volunteers were included for the safety and tolerability of the endotoxin adsorber system. One single veno-venous hemoperfusion with this system was performed. Apheresis treatment with the human albumin immobilized adsorber seems to be safe and well tolerable in healthy volunteers. A slight decrease in platelet count as well as insulin level was observed. No serious adverse events were mentioned. Similar findings were made in an open uncontrolled trial in six patients with suspected Gram-negative sepsis. Here endotoxin adsorption seems to be safe and well tolerated without adsorber related major adverse events. In the last clinical trial including 145 patients mainly peritonitis patients (104), again no safety concerns were found during the apheresis. Trends in improvement of morbidity and organ dysfunction were found as well as efficient LPS removal in peritonitis patients. LPS whole blood immunoadsorption is a promising new method. No relevant side effects were observed so far. A large controlled study to prove clinical efficacy in patients with severe sepsis and confirmed endotoxemia (e.g. peritonitis) should be necessary.
Staubach
Karl-Hermann
KH
Department of Surgery, University Hospital of Leubeck, Ratzeburger Allee 160, 23538 Lübeck, Germany. karl-hermann.staubach@epost.de
Boehme
Marc
M
Zimmermann
Michael
M
Otto
Veit
V
D000327:Adsorption; D001781:Blood Component Removal / Q000295:instrumentation* / Q000379:methods*; D002986:Clinical Trials as Topic; D004731:Endotoxins / Q000378:metabolism*; D005260:Female; D006090:Gram-Negative Bacteria / Q000378:metabolism*; D006801:Humans; D008070:Lipopolysaccharides / Q000378:metabolism; D008297:Male; D018805:Sepsis / Q000628:therapy*; D012709:Serum Albumin / Q000378:metabolism
D004731:Endotoxins; D008070:Lipopolysaccharides; D012709:Serum Albumin